BENSALEM, Pa., Aug. 29, 2007 LAWFUEL – The Legal Newswire — Law Offices of Howard G. Smith announces that it is investigating claims against Sciele Pharma, Inc. (“Sciele Pharma” or the “Company”) (Nasdaq:SCRX) (formerly, “First Horizon Pharmaceutical Corporation”) concerning whether the Company’s 401(k) Plan (the “Plan”) imprudently invested in Sciele Pharma stock and whether Plan administrators breached their fiduciary duties to Plan participants in violation of the Employee Retirement Income Security Act of 1974.
The investigation concerns whether the administrators of the Plan failed to prudently and loyally manage the Plan’s investment by offering Sciele stock, and whether the stock was a prudent investment for participants’ retirement savings.
If you are a current or former employee who participated in, or continues to participate in, the Sciele Pharma 401(k) Plan and have information or would like to learn more about these claims, please contact Howard Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at
(215) 638-4847, Toll-Free at (888) 638-4847, or by email to howardsmithlaw@hotmail.com.
If you wish to discuss these claims, or have any questions concerning this Notice or your rights or interests with respect to these matters, please contact Smith & Smith LLP, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone, Toll-Free at (888) 638-4847, or by email to howardsmithlaw@hotmail.com.
